Abstract
Current Pharmaceutical Design
Title: Editorial [Hot Topic: Recent Discoveries in the Search for Novel Antidepressants and Anxiolytics (Executive Editors: D. Bleakman and D. Gehlert)]
Volume: 11 Issue: 12
Author(s): David Bleakman and Donald Gehlert
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bleakman David and Gehlert Donald, Editorial [Hot Topic: Recent Discoveries in the Search for Novel Antidepressants and Anxiolytics (Executive Editors: D. Bleakman and D. Gehlert)], Current Pharmaceutical Design 2005; 11 (12) . https://dx.doi.org/10.2174/1381612053764841
DOI https://dx.doi.org/10.2174/1381612053764841 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Inhibition of Monoamine Neurotransmitter Transporters andCentral Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review
Current Medicinal Chemistry - Central Nervous System Agents Changes in Attachment Representations During an Open Trial of a Psychological Intervention for Adolescents with Learning Disorders
Adolescent Psychiatry Binding Model of Capsaicin is Able to Reach the Peripheral Anionic Site of Acetylcholinesterase
Current Bioactive Compounds Withania somnifera Phytochemicals Confer Neuroprotection by Inhibition of the Catalytic Domain of Human Matrix Metalloproteinase-9
Letters in Drug Design & Discovery Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Induction of Apoptotic Cell Death in Tumor Cells by S100A8/A9 Released from Inflammatory Cells Upon Cellular Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Effect of ACT on Self-Esteem and Self-efficacy of Women with Breast Cancer in Iran
Current Women`s Health Reviews Analgesic and CNS Depressant Activities of Sea Anemone Heteractis aurora Nematocyst Toxin
Central Nervous System Agents in Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
Recent Patents on CNS Drug Discovery (Discontinued) Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease
Current Alzheimer Research P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer
Current Drug Targets Drug Targets from Genetics: Alpha-Synuclein
CNS & Neurological Disorders - Drug Targets Predicting Drug Metabolism Induction In Silico
Current Topics in Medicinal Chemistry Targeting Toll-like Receptors in Autoimmunity
Current Drug Targets COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact
Current Pharmaceutical Design Phage-Displayed Combinatorial Peptide Libraries in Fusion to β-Lactamase as Reporter for an Accelerated Clone Screening: Potential Uses of Selected Enzyme-Linked Affinity Reagents in Downstream Applications
Combinatorial Chemistry & High Throughput Screening Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Editorial (Hot Topic: Neuroprotection Against Stroke and CNS Injury: New Mechanisms, Targets, and Controversies)
CNS & Neurological Disorders - Drug Targets